reference/28171011

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28171011

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1402
issn	0149-2918
issueIdentifier	7
pageRange	1390-1402
publicationName	Clinical Therapeutics
startingPage	1390
bibliographicCitation	Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study. Clin Ther. 2007 Jul;29(7):1390–402. doi: 10.1016/j.clinthera.2007.07.021. PMID: 17825690.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef4a802cb9193084b157681dec118057 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_41f28b547e8246d5cf72a18495cad264 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b2b4272320c34b9a0de5cf9d7d1af18 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc1d851863a24e06d6202195a9921004 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d107c70c6f8de47433648cff481b711 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aabeec6eeb20508dbd13b4e41db81216
date	200707
identifier	https://doi.org/10.1016/j.clinthera.2007.07.021 https://pubmed.ncbi.nlm.nih.gov/17825690
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2822 https://portal.issn.org/resource/ISSN/0149-2918
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Tolerability of a Salmeterol Xinafoate/Fluticasone Propionate Hydrofluoroalkane Metered-Dose Inhaler in Adolescent and Adult Patients with Persistent Asthma: A 52-Week, Open-Label, Stratified, Parallel-Group, Multicenter Study
discusses	http://id.nlm.nih.gov/mesh/M0001108 http://id.nlm.nih.gov/mesh/M000623538 http://id.nlm.nih.gov/mesh/M0000716 http://id.nlm.nih.gov/mesh/M0010707 http://id.nlm.nih.gov/mesh/M0002975 http://id.nlm.nih.gov/mesh/M0000494 http://id.nlm.nih.gov/mesh/M0006823 http://id.nlm.nih.gov/mesh/M0000631
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000420Q000031 http://id.nlm.nih.gov/mesh/D001249Q000188 http://id.nlm.nih.gov/mesh/D001993Q000627 http://id.nlm.nih.gov/mesh/D000318Q000627 http://id.nlm.nih.gov/mesh/D000730Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000318Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D000473 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D000318Q000009 http://id.nlm.nih.gov/mesh/D001993Q000008 http://id.nlm.nih.gov/mesh/D004562 http://id.nlm.nih.gov/mesh/D000068297 http://id.nlm.nih.gov/mesh/D000420Q000008 http://id.nlm.nih.gov/mesh/D000730Q000009 http://id.nlm.nih.gov/mesh/D000730Q000008 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006854Q000652 http://id.nlm.nih.gov/mesh/D012129 http://id.nlm.nih.gov/mesh/D000420Q000009 http://id.nlm.nih.gov/mesh/D000420Q000627 http://id.nlm.nih.gov/mesh/D002648 http://id.nlm.nih.gov/mesh/D036501 http://id.nlm.nih.gov/mesh/D004338 http://id.nlm.nih.gov/mesh/D001993Q000009 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8600 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6985 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56801 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9083 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444036 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2083

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129604518 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128684764 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128344927 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136316904 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127958259

Total number of triples: 73.